• Citer

Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer

par Nuciforo, Paolo Giovanni;Townend, John;Piccart-Gebhart, Martine ;Fielding, Shona;Gkolfi, Panagiota;El-abed, Sarra;de Azambuja, Evandro ;Werutsky, Gustavo;Bliss, Judith M;Mobus, Volker;Colleoni, Marco Angelo;Moreno-Aspitia, Alvaro;Gomez, H.L.;Gombos, Andrea ;Coccia-Portugal, Maria Antonia;Tseng, Ling Min;Kunz, Georg;Lerzo, Guillermo;Sohn, Joohyuk;Semiglazov, Vladimir;Saura, Cristina;Kroep, Judith;Ferro, Antonella;Cameron, David A;Gelber, Richard;Huober, J.;Di Cosimo, Serena
Référence European journal of cancer, 181, page (92-101)
Publication Publié, 2023-03-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer
Auteur:	Nuciforo, Paolo Giovanni; Townend, John; Piccart-Gebhart, Martine; Fielding, Shona; Gkolfi, Panagiota; El-abed, Sarra; de Azambuja, Evandro; Werutsky, Gustavo; Bliss, Judith M; Mobus, Volker; Colleoni, Marco Angelo; Moreno-Aspitia, Alvaro; Gomez, H.L.; Gombos, Andrea; Coccia-Portugal, Maria Antonia; Tseng, Ling Min; Kunz, Georg; Lerzo, Guillermo; Sohn, Joohyuk; Semiglazov, Vladimir; Saura, Cristina; Kroep, Judith; Ferro, Antonella; Cameron, David A; Gelber, Richard; Huober, J.; Di Cosimo, Serena
Informations sur la publication:	European journal of cancer, 181, page (92-101)
Statut de publication:	Publié, 2023-03-01
Sujet CREF:	Cancérologie
Mots-clés:	Breast cancer
	Dual anti-HER2 blockade
	HER2-Positive
	Long-term survival
	Neoadjuvant
	Pathological complete response
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2022.12.020
	info:pii/S0959804922018317
	info:scp/85146155206
	info:pmid/36641898